This biotech inventory soared 20% final week, and analysts give 36% upside
U.S. biotech agency Horizon Therapeutics was among the many prime world performers final week, with its inventory hovering practically 21% for the week. The corporate, which produces therapies for folks with autoimmune and extreme…